Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2007-06-05
2007-06-05
Chism, B. Dell (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S002600, C930S170000
Reexamination Certificate
active
11262067
ABSTRACT:
Methods for treating female sexual dysfunction are provided. A pharmaceutical composition containing a vasoactive agent selected from vasoactive intestinal potypeptide (VIP) and VIP agonists is administered to the vagina and/or vulvar region of the individual undergoing treatment. The formulations are also useful for improving vaginal muscle tone and tissue health, enhancing vaginal lubrication, and minimizing excess collagen deposition. Pharmaceutical formulations and kits are also provided.
REFERENCES:
patent: 5217953 (1993-06-01), Gozes et al.
patent: 5376637 (1994-12-01), Sawai et al.
patent: 5428015 (1995-06-01), Kurono et al.
patent: 5565424 (1996-10-01), Gozes et al.
patent: 5612314 (1997-03-01), Stamler et al.
patent: 5877216 (1999-03-01), Place et al.
patent: 5972883 (1999-10-01), Gozes et al.
patent: 5998368 (1999-12-01), Gozes et al.
patent: 6031002 (2000-02-01), Wysor et al.
patent: 6051555 (2000-04-01), Hadley
patent: 6103765 (2000-08-01), Neal
patent: 6217886 (2001-04-01), Önyüksel et al.
patent: 6239107 (2001-05-01), Gozes et al.
patent: 6266560 (2001-07-01), Zhang et al.
patent: 6300335 (2001-10-01), Campbell et al.
patent: 2005/0075284 (2005-04-01), Gozes et al.
patent: 0 295 317 (1988-12-01), None
patent: 0 755 685 (1997-01-01), None
patent: WO 01/17479 (2001-03-01), None
patent: WO 01/90144 (2001-11-01), None
Jia et al. 1999, European Journal of Pharmacology, vol. 366, pp. 79-86.
Levin, R.J.,VIP, Vagina, Clitoral and Periurethral Glans—An Update on Human Female Genital Arousal, Exp. Clin. Endocrinol. 98(2):61-69 (1991).
Ottensen et al.,Vasoactive Intestinal Polypeptide(VIP)Provokes Vaginal Lubrication in Normal Women, PEPTIDES 8:797-800 (1987).
Ottensen et al.,Influence of Pregnancy and Sex Steroids on Concentration, Motor Effect, and Receptor Binding of VIP in the Rabbit Female Genital Tract, Regulatory Peptides 11:83-92 (1985).
Place Virgil A.
Wilson Leland F.
Chism B. Dell
Mintz Levin Cohn Ferris Glovsky and Popeo P.C.
Rutenberg Isaac M.
Schneider Carol
Vivus Inc.
LandOfFree
Treatment of female sexual dysfunction with vasoactive... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of female sexual dysfunction with vasoactive..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of female sexual dysfunction with vasoactive... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3812149